AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Economic evaluation protocol for a randomised controlled trial-based equivalence study
Ponego Lloyd Ponatshego, David Stephen Lawrence, Nabila Youssouf, Sile F. Molloy, Melanie Alufandika, Funeka Bango, David R Boulware, Chimwemwe Chawinga, Eltas Dziwani, Ebbie Gondwe, Admire Hlupeni, Mina C. Hosseinipour, Cecilia Kanyama, David B. Meya, Mosepele Mosepele, Charles Muthoga, Conrad K. Muzoora, Henry Mwandumba, Chiratidzo E. Ndhlovu, Radha RajasinghamSumaya Sayed, Shepherd Shamu, Katlego Tsholo, Lillian Tugume, Darlisha Williams, Hendramoorthy Maheswaran, Tinevimbo Shiri, Timothée Boyer-Chammard, Angela Loyse, Tao Chen, Duolao Wang, Olivier Lortholary, David G. Lalloo, Graeme Meintjes, Shabbar Jaffar, Thomas S. Harrison, Joseph N. Jarvis, Louis Wilhelmus Niessen
Dive into the research topics of 'AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: Economic evaluation protocol for a randomised controlled trial-based equivalence study'. Together they form a unique fingerprint.